Cargando…
1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781577/ http://dx.doi.org/10.1093/ofid/ofu052.1121 |
_version_ | 1783294988651593728 |
---|---|
author | Krishna, Rajesh Rizk, Matthew Schulz, Valerie Bruggencate-Broeders, Jolanda Liu, Ran Larson, Patrick Abou-Farha, Khalid |
author_facet | Krishna, Rajesh Rizk, Matthew Schulz, Valerie Bruggencate-Broeders, Jolanda Liu, Ran Larson, Patrick Abou-Farha, Khalid |
author_sort | Krishna, Rajesh |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5781577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57815772018-03-01 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects Krishna, Rajesh Rizk, Matthew Schulz, Valerie Bruggencate-Broeders, Jolanda Liu, Ran Larson, Patrick Abou-Farha, Khalid Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781577/ http://dx.doi.org/10.1093/ofid/ofu052.1121 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
spellingShingle | IDWeek 2014 Abstracts Krishna, Rajesh Rizk, Matthew Schulz, Valerie Bruggencate-Broeders, Jolanda Liu, Ran Larson, Patrick Abou-Farha, Khalid 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title | 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title_full | 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title_fullStr | 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title_full_unstemmed | 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title_short | 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
title_sort | 1575 a 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects |
topic | IDWeek 2014 Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781577/ http://dx.doi.org/10.1093/ofid/ofu052.1121 |
work_keys_str_mv | AT krishnarajesh 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT rizkmatthew 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT schulzvalerie 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT bruggencatebroedersjolanda 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT liuran 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT larsonpatrick 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects AT aboufarhakhalid 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects |